Mubadala Investment Co PJSC 13D and 13G filings for Recursion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-31 4:08 pm Purchase | 2022-10-27 | 13D | Recursion Pharmaceuticals, Inc. RXRX | Mubadala Investment Co PJSC | 11,291,937 6.300% | 2,551,020 (+29.18%) | Filing |
| 2021-11-04 5:27 pm Unchanged | 2021-11-01 | 13D | Recursion Pharmaceuticals, Inc. RXRX | Mubadala Investment Co PJSC | 8,740,917 5.500% | 0 (Unchanged) | Filing |
| 2021-04-26 4:34 pm Purchase | 2021-04-16 | 13D | Recursion Pharmaceuticals, Inc. RXRX | Mubadala Investment Co PJSC | 8,740,917 5.700% | 8,740,917 (New Position) | Filing |